Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Inicio Explorar nav.journalClub Tendencias

⌘+K

A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection | Synapse

October 3, 2024Science82 citations

A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection

Ver artículo completo

MAMohamad‐Gabriel Alameh ASAlexa Semon NBNile U. Bayard

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

infection (CDI) is an urgent public health threat with limited preventative options. In this work, we developed a messenger RNA (mRNA)-lipid nanoparticle (LNP) vaccine targeting

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Alameh et al. (2024) studied this question.

synapsesocial.com/papers/68e55db1e2b3180350efafba https://doi.org/10.1126/science.adn4955

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses2022 · 80 citations
2Definition of the single integration site of the pathogenicity locus in Clostridium difficile1996 · 325 citations
3A Review of the Safety and Efficacy of Vaccines as Prophylaxis for Clostridium difficile Infections2017 · 37 citations
4A new method for non‐parametric multivariate analysis of variance2001 · 13,469 citations
5Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation2021 · 12,148 citations